Multiple Sclerosis Society

Tripadvisor Co-Founder Launches New Venture: Give Freely, a Shopping Assistant That Finds Coupons and Donates Sales Commissions to Charities as Consumers Shop

Retrieved on: 
Thursday, October 26, 2023
Multiple Sclerosis Society of Great Britain, Child, Spectrum, The Michael J. Fox Foundation, EVP, National Multiple Sclerosis Society, Water, Human, Choose Love, MJFF, UNICEF, SVP, Parkinson's disease, Life, Refugee, Family, Business development, News, UNICEF USA, Believer, Research, Creativity, Infant, Senior, Multiple Sclerosis Society, Internet, Disease, Organic, Health equity, Partnership, Breast cancer, Rosales, Commerce, Founding, Movement, Patient, Philanthropy, Death, Cryptocurrency, Online shopping, Music, Management, Tourism, Development, Tripadvisor

BOSTON, Oct. 26, 2023 /PRNewswire/ -- Steve Kaufer, the visionary co-founder and longtime leader of Tripadvisor, is excited to announce the launch of Give Freely, a mission-driven company incorporated with the sole purpose of harnessing the collective power of online commerce for charitable good. The company's revolutionary first product is an online shopping assistant that helps people find discounts and donate to the charities of their choice while they shop online. The donations are generated from retailer-paid affiliate marketing sales commissions that other coupon companies pocket as a profit, but Give Freely will divert those funds to charities in desperate need of funding. 100% of every affiliate dollar that comes to Give Freely goes to the user's favorite charity.

Key Points: 
  • The company's revolutionary first product is an online shopping assistant that helps people find discounts and donate to the charities of their choice while they shop online.
  • Consumers can choose which charity they want donations directed to from a pool of over 1.1 million non-profits.
  • "I've always been a believer in the power of large communities taking small, individual actions, and having large collective impacts.
  • With Tripadvisor, that vision led to hundreds of millions of review contributors helping billions of travelers have a better vacation.

Lisa McCoy Joins Defeat Duchenne Canada as New CEO

Retrieved on: 
Tuesday, October 24, 2023
Heart, American Cancer Society, Jesse's Journey, Heart and Stroke Foundation of Canada, Tourette Canada, Multiple Sclerosis Society, Duchenne muscular dystrophy, Executive, Stroke, Patient, Canadian Cancer Society, Management, Nursing, Duchenne

Defeat Duchenne Canada appoints Lisa McCoy as new CEO.

Key Points: 
  • Defeat Duchenne Canada appoints Lisa McCoy as new CEO.
  • "I am thrilled to join the Defeat Duchenne Canada team and contribute to the vital vision: a future without Duchenne," said Lisa McCoy.
  • "We are confident that Lisa will provide the visionary leadership required to take Defeat Duchenne Canada to new heights," said Brain Atkinson, Chair of the Board of Directors at Defeat Duchenne Canada.
  • Lisa McCoy assumes her role as CEO of Defeat Duchenne Canada immediately.

Find Therapeutics welcomes Dr. Jack Antel to its clinical advisory board

Retrieved on: 
Monday, May 1, 2023
Sclerosis, Optic neuritis, Multiple Sclerosis Journal, Cleveland Clinic, Specialist, University, CAB, National Multiple Sclerosis Society, Clinical trial, KNEEMO Initial Training Network, American Academy, Research, University of Ottawa Heart Institute, Department of Neurology, Xuanwu hospital, Multiple sclerosis, MS, Teaching hospital, Multiple Sclerosis Society, Neuro-ophthalmology, Patient, Montreal Neurological Institute and Hospital, University of Genoa, McGill University Health Centre, Soft tissue injury, McGill University, ISCB Senior Scientist Award, Ottawa Hospital Research Institute, Neurosurgery, American Academy of Neurology, Therapy, International Society, Pharmaceutical industry, Management, Medical device, Neurology, Biostatistics

MONTREAL, May 1, 2023 /PRNewswire/ - Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced the appointment of Dr. Jack Antel to its Clinical Advisory Board (CAB).

Key Points: 
  • MONTREAL, May 1, 2023 /PRNewswire/ - Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced the appointment of Dr. Jack Antel to its Clinical Advisory Board (CAB).
  • Dr. Antel joins a CAB with considerable expertise in neuro-ophthalmology whose members have decades of clinical practice with optic neuritis patients as well as clinical trial expertise and peer-reviewed publications in this condition.
  • Dr. Antel is an internationally acclaimed clinical neurologist and thought leader who coordinates the multiple sclerosis research and treatment program at the Montreal Neurological Institute.
  • "We are honored and delighted to welcome Dr. Antel to our Clinical Advisory Board.

Pathways to Cures are in Sight as MS Canada Hosts Annual Day on the Hill with Carnation Pinning

Retrieved on: 
Monday, May 1, 2023
Vaccine, MS Communications, Multiple sclerosis research, Infection, Multiple Sclerosis Society of Canada, Poverty, Communication, Partnership, Central nervous system, University, Senate, Senior, EBV, Harvard University, Multiple, Disability, Commons, Spinal cord, Long-term care, Public, Unemployment benefits, Epstein–Barr virus, Research, Brain, House of Commons, Multiple sclerosis, CNS, MS, Multiple Sclerosis Society, Employment, Regeneration, Housing, Autoimmune disease, Immune system, Lifting, Optic nerve, McGill, Health Canada, Woman, House, Social media, Health insurance, Drug, Nursing, Medical device

The distanced “self-pinning” replaces the traditional annual pinning by MS Canada representatives in the parliamentary foyers.

Key Points: 
  • The distanced “self-pinning” replaces the traditional annual pinning by MS Canada representatives in the parliamentary foyers.
  • Public officials across Canada and members of the public are also invited to join in showing their support on May 3rd through MS Canada’s digital carnation pinning platform.
  • At the start of 2023, the Multiple Sclerosis (MS) Society of Canada began operating under a new name – MS Canada.
  • It could potentially eradicate MS altogether.” – Benjamin Davis, Senior Vice-President of MS Canada
    “Two decades ago, I started volunteering with MS Canada to support people like me who live with MS and to raise funds for MS research.

FSD Pharma Achieves Milestone in Completion of Dosing of Sentinel Subjects in First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis

Retrieved on: 
Monday, April 17, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, Infection, Injection, CSE, Central nervous system, Depression, Prevalence, FSD, Spasm, Anxiety, Blurred vision, Spinal cord, Atlas, Clinical trial, Deficit spending, Hypoesthesia, Research, Brain, Immobilization, Multiple sclerosis, FRA, MS, Multiple Sclerosis Society, Pain, Nerve, New chemical entity, Fatigue, Dizziness, Death, Patient, Respiratory failure, FIH, Diagnosis, Safety, Disease, Pharmaceutical industry, Lithium

The sentinel dose was completed on Sunday, April 16, 2023.

Key Points: 

icometrix & Queen Mary University of London receive prestigious AI Award from the National Institute for Health and Care Research (NIHR) to investigate the impact of AI applied to MRI in the care of people with multiple sclerosis (MS)

Retrieved on: 
Friday, March 3, 2023
Queen Mary University of London, Care, Multiple sclerosis, Pressure, Barts Health NHS Trust, Neurology, Quality of life, InHealth Group, Nottingham University Hospitals NHS Trust, MRI, Head, Publication, Radiology, News, Software, University, DMT, Brain, Multiple Sclerosis Society, NHS, Research, MS, PPI, QMUL, Central nervous system, AI, Neuro, Patient, NIHR, Medical imaging, Pharmaceutical industry

LONDON, March 3, 2023 /PRNewswire/ -- icometrix is proud to announce that, together with Queen Mary University of London (QMUL), it has been awarded the prestigious AI Award in Health and Care. This collaborative program will investigate the impact of AI on the assessment of MRI and decision making in the context of multi-disciplinary team meetings for people with MS. It is hoped that this research will lead to better care for people with MS (pwMS).

Key Points: 
  • The programme called AssistMS, is a collaboration between icometrix, QMUL, the University of Nottingham, and Barts Health and Nottingham University Hospitals Trusts.
  • The project is further supported by the East Midlands Imaging Network (EMRAD), InHealth Group and the MS Society of Great Britain & Northern Ireland.
  • pwMS receiving disease-modifying treatments (DMT) undergo annual MRI of the central nervous system to monitor disease activity.
  • Our joint efforts will undoubtedly transform care and improve outcomes for many PwMS for the better across Europe and beyond."

icometrix & Queen Mary University of London receive prestigious AI Award from the National Institute for Health and Care Research (NIHR) to investigate the impact of AI applied to MRI in the care of people with multiple sclerosis (MS)

Retrieved on: 
Friday, March 3, 2023
Queen Mary University of London, Care, Multiple sclerosis, Pressure, Barts Health NHS Trust, Neurology, Quality of life, InHealth Group, Nottingham University Hospitals NHS Trust, MRI, Head, Publication, Radiology, News, Software, University, DMT, Brain, Multiple Sclerosis Society, NHS, Research, MS, PPI, QMUL, Central nervous system, AI, Neuro, Patient, NIHR, Medical imaging, Pharmaceutical industry

LONDON, March 3, 2023 /PRNewswire/ -- icometrix is proud to announce that, together with Queen Mary University of London (QMUL), it has been awarded the prestigious AI Award in Health and Care. This collaborative program will investigate the impact of AI on the assessment of MRI and decision making in the context of multi-disciplinary team meetings for people with MS. It is hoped that this research will lead to better care for people with MS (pwMS).

Key Points: 
  • The programme called AssistMS, is a collaboration between icometrix, QMUL, the University of Nottingham, and Barts Health and Nottingham University Hospitals Trusts.
  • The project is further supported by the East Midlands Imaging Network (EMRAD), InHealth Group and the MS Society of Great Britain & Northern Ireland.
  • pwMS receiving disease-modifying treatments (DMT) undergo annual MRI of the central nervous system to monitor disease activity.
  • Our joint efforts will undoubtedly transform care and improve outcomes for many PwMS for the better across Europe and beyond."

MS Canada Partners with Sesh to Provide Free Mental Health Resource for People Living with MS

Retrieved on: 
Wednesday, February 1, 2023
Apps, Applications, Technology, Mental Health, Other Technology, Telemedicine, Virtual Medicine, Software, Managed Care, Health, General Health, Multiple sclerosis research, Organization, Caregiver, Life, Depression, Grief, Research, Risk, Anxiety, Multiple Sclerosis Society, Partnership, Multiple sclerosis, MS, Mental health, Nursing

MS Canada (formerly the MS Society of Canada) has partnered with mental health app Sesh to provide the Sesh platform free of charge to Canadians living with MS to support their wellness journeys .

Key Points: 
  • MS Canada (formerly the MS Society of Canada) has partnered with mental health app Sesh to provide the Sesh platform free of charge to Canadians living with MS to support their wellness journeys .
  • "Our partnership is much more than an endorsement: it's nationwide advocation for the Sesh support group model and its impact on clinical outcomes."
  • Since 1948, the MS Society has provided support, advocacy, and resources for people living with MS, as well as their families and caregivers.
  • "Partnering with Sesh is an important step in providing improved access to much needed mental health support for the MS community," said Dr. Pamela Valentine, President and CEO of MS Canada.

Capital Square Reports Record Year: $2.29 Billion in Acquisitions and More Than $1 Billion in Equity Raised in 2022

Retrieved on: 
Wednesday, January 18, 2023
REIT, Capital, BFR, DST, Capital Square, Magic Circle (law firms), Hospital, National Multiple Sclerosis Society, National Capital Chapter, Children's Hospital, Trauma surgery, Multiple Sclerosis Society, VCU, Internal Revenue Code, Internal Revenue Code section 1031, Acquisition, Investment, Commercial property, Financial services

The firm also launched a new build-for-rent (BFR) division, Private Equity Group, that focuses on single-family build-for-rent home acquisitions and development opportunities.

Key Points: 
  • The firm also launched a new build-for-rent (BFR) division, Private Equity Group, that focuses on single-family build-for-rent home acquisitions and development opportunities.
  • "2022 was another record year for Capital Square, exceeding acquisition and fundraising goals for DST and opportunity zone funds," said Louis Rogers, founder and co-chief executive officer of Capital Square.
  • Capital Square's annual equity raise of over $1 billion was a new record for the firm and an approximately 20% increase over 2021.
  • In keeping with the company's ongoing commitment to building a better future, Capital Square initiated "Capital Square Cares" in 2022 to spearhead the firm's growing charitable endeavors.

Government of Canada improves sickness benefits under the Employment Insurance system

Retrieved on: 
Friday, November 25, 2022
Canada Labour Code, Minister of Employment, Workforce Development and Disability Inclusion, Unemployment benefits, Quarantine, Sick leave, Government, Multiple Sclerosis Society, Enlisted Evaluation Report, American Cancer Society, PRP, Sickness, Insurance, Cancer, Unemployment, MS, Injury, Federal aid during the COVID-19 pandemic in Canada, Disease, Disability, Multiple sclerosis, Canadian Cancer Society, American Cancer Society Cancer Action Network, Diagnosis, Government of Canada, Employment, CCS, Health, Workplace, Paycheck, Health insurance, Creative industries, Pharmaceutical industry, EI

That is why the Government of Canada is taking action to improve Employment Insurance (EI) sickness benefits.

Key Points: 
  • That is why the Government of Canada is taking action to improve Employment Insurance (EI) sickness benefits.
  • EI sickness benefits are paid at 55% of the applicant's average weekly insurable earnings, up to a maximum entitlement of $638 for 2022.
  • This change will come into effect on the same date as the extension of EI sickness benefits and will ensure that employees have the right to take unpaid job-protected leave while receiving the extended EI sickness benefits.
  • Claimants also need to get a medical certificate signed by a medical practitioner when they apply for sickness benefits.